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Abstract 
 
Flavocytochrome P450BM-3, is a soluble bacterial reductase composed of two flavin 
(FAD/FMN) and one HEME domains. In this paper, we have performed molecular dynamics 
simulations on both the isolated FMN and HEME domains and their crystallographic complex, 
with the aim to study their binding modes and to garner insight into the inter-domain electron 
transfer (ET) mechanism. The results evidenced an inter-domain conformational rearrangement 
that reduces the average distance between the FMN and HEME cofactors from 1.81 nm, in the 
crystal structure, to an average value of 1.41 ± 0.09 nm along the simulation. This modification 
is in agreement with previously proposed hypotheses suggesting that the crystallographic 
FMN/HEME complex is not in the optimal arrangement for favorable ET rate under 
physiological conditions. The calculation of the transfer rate along the simulation, using the 
Pathway method, demonstrated the occurrence of seven ET pathways between the two redox 
centers, with three of them providing ET rates (KET) comparable with the experimental one. The 
sampled ET pathways comprise the amino acids N319, L322, F390, K391, P392, F393, A399, 
C400 and Q403 of the HEME domain and M490 of the FMN domain. The values of KET were 
closer to the experiment were calculated along the pathways FMN(C7) à F390 à K391 à 
P392 à HEME(Fe) and FMN(C8) à M490 à F393 à HEME(Fe). Finally, the analysis of the 
collective modes of the protein complex evidences a clear correlation of the first two essential 
modes with the activation of the most effective ET pathways along the trajectory. 
 
Introduction 
The cytochrome P450BM-3 is an important representative of the large family of 
Cytochrome P450 monooxygenases.1-3 It is a NADPH-dependent fatty acid hydroxylase enzyme 
isolated from soil bacterium Bacillus megaterium.4,5 P450BM-3 is an attractive target and a 
model system for biochemical and biomedical applications for different reasons.6,7 First, it is a 
stable, catalytically self-sufficient protein with a convenient multidomain structure that allows 
easier production and handling than other monooxygenases of this family.8 Second, it is a water-
soluble enzyme with a high catalytic efficiency and oxygenase rate and it can be readily 
expressed recombinantly.9,10 Third, it resembles to eukaryotic diflavin reductase such as the 
human microsomal P450s. As a pivotal member of P450 superfamily, it has been widely studied 
as an important model system for the comprehension of structure-function-dynamics 
relationships. The wealth of structural and kinetic data makes it one of the most studied 
enzyme.11,12  
P450BM-3, being a multidomain protein has two reductase, flavin adenine dinucleotide 
(FAD)- and flavin mononucleotide (FMN)- binding domains and a HEME-binding domain 
arranged as HEME-FMN-FAD on a single polypeptide chain.13,14 The main catalytic function of 
P450s is to transfer oxygen atom from molecular oxygen to their substrates. During the reaction, 
the enzyme is reduced by NADPH, with the electrons first transferred to the FAD cofactor of the 
FAD-binding domain and then to the HEME iron of the substrate bound HEME-binding domain 
mediated by the FMN cofactor of the FMN-binding domain. The crystallization of the whole 
P450BM-3 protein has been proven difficult due to the presence of flexible linker regions 
between domains. However, the crystallographic structures of the isolated HEME domain15, 
FAD domain16 and a non-stoichiometric complex with one FMN and two HEME domains15 are 
available in the PDB database. In the crystallographic FMN/HEME complex (PDB ID: 1BVY), 
the edge-to-edge shortest distance between redox centers is 1.81 nm.15 However, it has been 
shown from a survey of electron transfer (ET) in the oxidoreductase proteins that  a distance less 
than 1.40 nm is required between the redox centers for an efficient ET tunneling in the protein 
environment.17 In addition, Munro et al. 11, have proposed that the rearrangement of the FMN 
domain in the structure of the crystallographic HEME/FMN complex is essential to decrease the 
distance between the FMN and HEME cofactors within the physiological range (less than 1.40 
nm) for ET.11 This hypothesis was corroborated by previous experimental evidences suggesting   
that the catalytic efficiency of P450BM-3 is determined by a optimal arrangement of the HEME 
and FMN domains.18 
In this study, we aim to extend our knowledge regarding structure-function-dynamics 
relationships in P450BM-3 at molecular level using molecular dynamics (MD) simulations of the 
isolated HEME and FMN domains and of the FMN/HEME complex in solution.  Previous MD 
simulations studies from our group have focused on the structure and dynamics of the isolated 
HEME and FMN domains.19-21 Herein, the analysis will be focused on the relative rearrangement 
of the FMN and HEME domains in their complex and how it affects the ET tunneling from the 
FMN isoalloxazine ring to the HEME iron. To the best of our knowledge, this is the first MD 
study of this type on this system. 
The paper is organized as follows. The details of the force field and MD simulations are 
reported in the Method section. In the first part of the subsequent Results and Discussion section, 
the general structural properties of the simulated systems are reported and discussed. In 
particular, cluster analysis is used to identify representative conformations and to evidence the 
structural differences of the domains in the solution and complex. The crystallographic structure 
and selected conformations from the trajectory are then used to analyze the possible 
FMN/HEME ET pathways using the Pathways method.22 The structural variations of other 
relevant part of the enzyme as the substrate access channel and the water coordination with the 
HEME iron are also reported. Hence, the collective dynamics of the system is analyzed using the 
principal component analysis of the trajectories and the essential modes are correlated with the 
KET calculated using the more efficient pathways. Finally, the conclusion section summarizes the 
outcome of the study. 
 
Methods 
Starting coordinates 
The non-stoichiometric FMN/(HEME)2 complex of one FMN domain and two HEME 
domains without substrate (PDB ID: 1BVY with resolution 0.203 nm)15 were used to obtain the 
starting coordinate for the MD simulation. One of the two HEME domains (chain A: 20 - 450) 
was in the close proximity of the FMN domain (chain F: 479 - 630) in the crystal structure. 
Hence, the latter A and F chains were extracted from the crystal structure (including 
crystallographic water within 0.60 nm from the domains) and used as the starting coordinates for 
the MD simulation. 1,2-ethanediol molecules were removed from the crystallographic structure 
and replaced by water molecules.   
 
Molecular dynamic simulations 
The GROMOS96 43a1 force field23 was used for all the simulations. The MD simulations 
performed in this study are summarized in Table 1. Figure 1 shows the FMN and HEME 
cofactors in stick representation. The parameters for the ferric iron of the HEME cofactor were 
adopted from Helms et al.24 and have been used already for the MD simulation of the P450BM-3 
HEME domain by Roccatano et al..19,20 Some of the partial charges were redistributed on the 
porphyrin ring of the HEME cofactor to adjust the parameters to the topology of GROMOS96 
43a1 force field23 with explicit hydrogen atoms bound to the bridging carbon in the porphyrin 
ring (see Table S1 in supporting information (SI)).  
The FMN cofactor is considered being in oxidized state in the FMN domain. In a 
previous publication, we improved the GROMOS model of FMN cofactor by adding additional 
improper dihedrals to adopt the conformation of the FMN isoalloxazine ring as observed in the 
crystallographic structure and in quantum mechanical calculations of flavin in both redox 
states.21,25 Here, the MD simulation of the isolated FMN domain is the continuation of the one 
reported in the previous publication. 21 
The isolated domains and their complex were centered in a cubic periodic box and set to 
have at least a minimal distance between the domain and any side of the box larger than 0.80 nm. 
They were solvated by stacking the equilibrated boxes of the solvent molecules to completely fill 
the simulation box. All the solvent molecules within the distance of 0.15 nm from the atoms of 
the domain were removed. The simulations were performed by using SPC model26 of water. 
Sodium counter ions were added by replacing water molecules at the most negative electrostatic 
potential to obtain a neutral simulation box. The protonation state of the residues in the protein 
was assumed to be the same as of the isolated amino acids in the solution at pH 7. All bond 
lengths were constrained by the LINCS27 algorithm. The SETTLE28 algorithm was used for the 
solvent molecules. The electrostatic interactions were calculated by using the Particle Mesh 
Ewalds (PME) method.29 For the long-range interactions, a grid spacing of 0.12 nm combined 
with a fourth-order B-spline interpolation were used to compute the potential and forces between 
grid points. A pair-list for non-bonded interactions within the cutoff of 1.3 nm was used and 
updated at every 5 time-steps. The simulated systems were first energy minimized, using the 
steepest descent algorithm, for at least 2000 steps in order to remove clashes between atoms that 
were too close. After energy minimization, initial velocities obtained from a Maxwell-Boltzmann 
velocity distribution at 300 K were assigned to all atoms. All systems were initially equilibrated 
for 100 ps with position restraints on the heavy atoms of the solute for the relaxation of the 
solvent molecules. Berendsen’s thermostat30 was used to keep the temperature at 300 K by weak 
coupling the systems to an external thermal bath with a time constant of 0.1 ps. The pressure of 
the system was kept at 1 bar by using the Berendsen’s barostat30 with a time constant of 1 ps. A 
time step of 2 fs was used to integrate the equations of motions. After the equilibration 
procedure, position restraints were removed and the system was gradually heated from 50 K to 
300 K in 200 ps. Finally, a production run of 100 ns was performed at 300 K for all the systems. 
All the simulations and analysis of the trajectories were performed by using the GROMACS 
(version 4.07) software package.31 The crystal structure of the P450BM-3 domains was used as 
reference structure for the analysis of all the simulations. During the simulations, the 
conformational changes occurred in the P450BM-3 domains were examined by analyzing the 
root mean square deviation (RMSD), root mean square fluctuation (RMSF), radius of gyration 
(Rg) and secondary structure elements (using DSSP criteria32) with respect to the crystal 
structure. 
 
Cluster analysis 
Cluster analysis was performed to characterize the conformational diversity of the 
structures generated during the MD simulations. It was performed using the Gromos clustering 
algorithm that is based on the RMSD of the selected atoms of the conformations obtained from 
the simulations.33 A structure is assigned to a cluster if its RMSD from the cluster median 
structure is within a given cutoff. In this work, the method was applied to the backbone atoms 
and a RMSD cutoff of 0.10 nm was used. For the analysis, 1400 structures were sampled at 
every 50 ps in the last 70 ns of the trajectories. 
 
Electron transfer tunneling 
 Electron transfer (ET) tunneling from the FMN to HEME cofactor was calculated using 
the Pathways program.22,34 For a given protein conformation, the program identifies an effective 
ET coupling by evaluating the highest electronic tunneling coupling (TDA) through different 
pathway connecting the donor and the acceptor through bonds and space.22 The Pathways 
program uses the graph theory to identify the series of steps to maximize TDA values by assigning 
different step contributions weather it is mediated by covalent bonds (εcb in equation 2), 
hydrogen bonds (εhb in equation 3) and through space jump (εsj in equation 4). Hence, TDA 
(equation 1) is proportional to the product of the latter contributions:  
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where R is the distance of the step i, j and k in Angstrom. The ET pathways between 
FMN/HEME were calculated in the crystal structure and by taking different conformations 
sampled along the MD trajectories. For the calculations, the C8 or C7 atom of the FMN 
isoalloxazine ring as donor and the HEME iron as acceptor were used. The ET pathways were 
calculated and visualized using the plugin Pathways34 and the visualization program VMD.35 The 
possible non-adiabatic ET reaction rate (KET) was estimated using the equation 5.36 
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where ΔG is the driving force and λ is the Marcus reorganization energy for the ET reaction, ħ 
= h/2π with h the Plank constant, and kB is the Boltzmann constant. The difference in the 
reduction potential of the FMN and HEME cofactor (-0.224 eV) was used as ΔG.11,14,17 λ was 
considered equal to 0.7 eV as a good approximation of the inter protein ET.11,17,37 
The average values of TDA and KET were calculated by evaluating along the trajectories 
the minimum lengths of the intermediate paths of the selected pathways. These distances were 
used to estimate, at each trajectory conformation the value of TDA and, hence, of KET using 
equation 1-5. Finally, the time series were used to calculate the mean and its standard deviation. 
 
Principal component analysis 
Principal component analysis (PCA) was performed to access the conformational space in the 
biomolecules during the MD simulation. The details of the PCA, also called as essential 
dynamics, can be found elsewhere.38,39 The backbone atoms (Cα, C and N) of the domains 
(considering 1773, 1317 and 456 atoms for AF, A and F chain, respectively) were used for the 
calculation of the covariance matrix. The PCA analysis was performed on the last 70 ns of the 
trajectories. For the 3D displacements along different eigenvectors were calculated by projecting 
the atomic coordinates along the trajectory on eigenvectors and by extracting sampled 
conformations along the two extremes of the projection. UCSF Chimera visualization tool is 
used for representation.40 The comparison of eigenvectors obtained from the different 
simulations was performed using the root-mean-square inner product (RMSIP in equation 6).41 
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where vi and uj are the ith and jth eigenvectors of the two different m dimensions essential 
subspaces of the two systems. RMSIP gives a simple measure to assess the dynamical similarity 
of eigenvectors.41 The convergence of the essential modes was performed by comparing the 
RMSIPs calculated from the MD trajectories.  
 
Results and Discussion 
Structural properties 
 Figure 2a shows the backbone RMSD of both the P450BM-3 domains as a function of 
time. The RMSD curves of both the AF chains and the single A chain converge to average 
RMSD values of 0.41 ± 0.03 nm and 0.36 ± 0.03 nm, respectively. The isolated A chain shows a 
slightly lower average RMSD value of 0.33 ± 0.02 nm. In the FMN/HEME complex, the RMSD 
of the F chain increases to an average value of 0.25 ± 0.02 nm in the last 10 ns. For the isolated F 
chain, the average RMSD value of 0.26 ± 0.02 nm was observed with a slight little variation at 
the end of simulation.21,25  
 In Figure 2b, the time series of the Rg values for the P450BM-3 domains are reported. 
The Rg values of the complex show a decrease of ~3.7% from the crystallographic value (2.42 
nm) in the first 10 ns with an average value of 2.33 ± 0.01 nm. The Rg variations of the A chain, 
in the complex and in solution with respect to the crystal structure (2.16 nm) is less than 1.8% 
(2.12 ± 0.01 nm and 2.14 ± 0.01 nm, respectively). The Rg value of the F chain does not vary 
significantly from the crystal structure (1.45 nm) with an average of 1.45 ± 0.01 nm and 1.46 ± 
0.01 nm for the single domain and the complex simulation, respectively.  
 The cytochrome P450BM-3 has structurally conserved P450- and flavodoxin- like protein 
folds in the A and F chains, respectively. Figure 3c shows the structure of FMN/HEME complex 
with the labeled helices of A (A to L) and F (α1 to α4) chain, and FMN binding loops (Lβ1, Lβ3 
and Lβ4). The loop regions are named according to the secondary structure element (α helix or β 
sheet) preceding them. The analysis of the secondary structure along the trajectories is reported 
in Figure S1 in SI.  The results of the analysis clearly indicate that the crystallographic secondary 
structure of the P450BM-3 domains remains fairly preserved in all the simulations. 
 Figure 3a and 3b show the per-residue RMSD and RMSF with respect to the crystal 
structure, respectively. The cofactor binding sites show smaller deviations and fluctuations from 
the crystal structure in the isolated (in red color) and complex (black color) simulations. For both 
the domains, the loop regions, and N- and C-termini show larger deviations. The isolated 
domains in solution deviate more than the one in the complex except the region between the 
helices, A - B, B’ - C, H - I, and K - L and in G helix of the A chain and Lβ3 of the F chain. The 
isolated F chain shows largest deviation in the Lβ2 and Lβ4 regions. In both the systems, the F 
chain shows higher fluctuation in the Lβ2 and Lα2 loops. In the simulation of the complex, the 
loop regions A/B, and F/G have larger fluctuations. Finally, in the simulation of the isolated F 
chain, the inner FMN cofactor binding loop (Lβ3) shows slightly higher fluctuations. 
 
Cluster analysis 
 For the AF chain, the first two clusters account for 46.16 % and 27.12 %, respectively. 
The analysis of trajectories from the isolated A and F chains in solution produced, 6 clusters in 
both the cases, whereas the one of the chain in the complex has returned 7 and 8 clusters, 
respectively. The first two clusters of the isolated A chain account for 46.53 % and 30.12 % of 
the population of conformers, respectively. However, the percentage for A chain changes to 
76.87 % and 10.99 %, respectively in the complex. For the F chain, the first cluster comprises the 
~64 % and the second 21.05 % and 23.05 % of the total conformations in the isolated and the 
complex simulation, respectively. The HEME domain is more liable for conformational changes 
when it is isolated than in the complex, while the F chain shows negligible difference in the 
conformational space in both the simulations. 
 In the complex simulation, the median structure of the first cluster for the AF chain 
shows a conformational rearrangement in both the domains that resulted into an increase in the 
compactness of the FMN/HEME complex (see Figure 2b and 4). Major differences were 
observed in the loop regions of the domains in all simulations. In Figure 4, the arrow shows the 
deviation from the crystal structure after inter-domain rearrangement that mainly involve G helix 
and H/I and K/L loops (residue 380 - 390) in the HEME domain and α2 helix of the FMN 
domain. The rearrangement decreases the edge-to-edge distance between both the FMN and 
HEME cofactors. The G helix and, H/I and K/L loop regions constitute the important part of the 
P450BM-3 HEME domain. The H/I and K/L loops are involved in the binding of the FMN 
domain and the residues 380 – 390 of K/L loop region head the HEME cofactor binding site 
therefore they might influence ET tunneling from FMN to HEME.  
 In the crystal structure, the minimum distance between the HEME and FMN domains is 
0.46 nm with a total number of 20 contacts. In the simulation of the complex, the latter distance 
decreased within the first 10 ns, then it stabilized to an average value of 0.37 ± 0.01 nm for the 
rest of the simulation (see Figure 5a). The number of contacts shows a sharp increase in the first 
10-20 ns and then it stabilizes to an average of 167 ± 14 contacts in the last 50 ns of the 
simulation (see Figure 5b). The change of the minimum distance and the number of contacts 
between the two domain strongly affect the ET tunneling (vide infra in the ET tunneling 
pathways section).   
 
Substrate access channel 
Pro45 and Ala191 are located at the mouth of the substrate access channel. In the crystal 
structure of the P450BM-3 complex, the P45Cα and A191Cα are 1.61 nm apart (0.87 nm in the A 
chain of 1BU7). Chang et. al. observed using MD simulations and docking approaches that the 
substrate binding was not dramatically affected by the closeness of the substrate access channel 
in P450BM-3.42 The behavior of the substrate access channel has been previously evaluated by 
monitoring the distance during the simulation between these two residues of the HEME domain 
(PDB code 1BU715) in solution by Roccatano et al..19 In Figure 6, the P45Cα - A191Cα distances 
were calculated in the isolated domain and complex simulations are reported. Both the 
simulations show higher variations in the P45Cα - A191Cα distance in the first 20 ns simulation. 
Conversely, in the isolated A chain, it stabilizes to the average distance of 1.11 ± 0.10 nm. In the 
simulation of the complex, the P45Cα - A191Cα distance continuously decreased until 32 ns and 
then it stabilizes to an average value of 0.59 ± 0.10 nm. The decrease in the P45Cα - A191Cα 
distances during the simulation indicating the closing of the mouth of the substrate access 
channel was observed and discussed previously by Roccatano et al..19 During the simulations, the 
more extended closure of the substrate access channel when HEME domain was in the complex 
then in solution that might be caused by the higher deviation of F/G loop in the complex 
simulation than in the solution. 
 
Water coordination with HEME iron 
Previous simulation by Roccatano et al.19 starting from the crystal structures of the 
individual  P450 BM3 HEME domain (PDB ID: 1BU7),15  have shown that although the water 
was not covalently bound to the HEME in the simulation model, the force field non covalent 
interactions between the iron and the water molecules could still provide a good approximation 
of the water coordination with an average Fe-O distance of ~0.3 nm compared to the 0.26 in the 
crystal.15  
Contrary to the 1BU7, the crystal structure of the HEME, in the FMN/HEME complex do 
not contain crystallographic water bound to the iron. However, the water molecules coordinating 
to the HEME iron were observed (consistently with the previous simulations of the 1BU7 
strcture) at an average distance of 0.28 ± 0.13 nm and of 0.34 ± 0.14 nm (see Figure S2 in SI) in 
the HEME domain during the isolated and the complex simulations, respectively. The 
coordination of iron by the water molecule is consistent with the configuration of the enzyme 
without the presence of the substrate.  
 
ET tunneling pathways 
 The minimum distance between the FMN isoalloxazine ring (using the heavy atoms only) 
and the HEME cofactor is reported in Figure S3 in SI (the simulation of the complex was 
extended till 150 ns to check the FMN/HEME distance convergence). During the complex 
simulation, the FMN/HEME distance decreases from 1.81 nm (in the crystal structure) to an 
average distance of 1.41 ± 0.09 nm, with the minimum distance of 1.02 nm. The decreased 
distances are within the range of expected ET between the redox centers17 (less than 1.50 nm) as 
proposed by Munro et al. 11 and consistent with experimental and theoretical observations.11,17 
Table 2 summarizes the ET pathways in AF chain calculated using the Pathways model 
(see Methods) in the crystal structure, the median conformation of the first cluster, the 
conformation with minimum FMN/HEME contact distance and those sampled every 10th ns from 
the 100 ns trajectory. The distributions of the total distances along the considered ET pathways 
are represented in the Figure S4 of SI. All the sampled pathways are characterized by through 
space (see equation 3). The most effective pathways are the first, second and seventh with high 
KET values (see Table 2) of 39.95 ± 0.7 s-1, 65 ± 1.0 s-1 and 20 ± 1.0 s-1, respectively. Figure 7a, 
7b and 7c show the FMN/HEME ET pathways identified by the Pathways model34  in the crystal 
structure (FMN/HEME distance of 1.81 nm), the median conformation of the first cluster 
(FMN/HEME distance of 1.41 nm) and the last conformation of the simulation (FMN/HEME 
distance of 1.27 nm), respectively. In the crystal structure, the ET tunneling from FMN to HEME 
cofactor is mediated by solvent molecules. After the conformational rearrangement in the AF 
chain, the FMN cofactor comes close to the HEME cofactor and eliminates the involvement of 
water molecules in the FMN/HEME ET tunneling for most of the time during the simulation.  In 
fact, only in the pathway from the configuration at 100 ns (see Figure 7c), the ET tunneling is 
mediated by Met490 and Gln403 residues with the involvement of a solvent molecule. When the 
FMN/HEME distance decrease from 1.8 nm (in crystal structure see Figure 7a) to 1.4 nm (just 
after rearrangement, see Figure 7b), a KET value of 65 ± 1.00 s-1 (Pathway 2 in Table 2) close to 
the experimental FMN/HEME KET value of 80 s-1 was obtained.43 
 
Principal component analysis 
In the simulations of the isolated domain and of the FMN/HEME complex, the 
cumulative sum of the relative positional fluctuation (RPF) is greater than 69% for the first 50 
eigenvectors of the A and F chains (reported in Figure S5 of SI). For the first twenty 
eigenvectors of A and F chains, the RMSIP was less than 0.53 in both the simulations. The inner 
product values were less than 0.25 and 0.43, respectively for the first three eigenvectors of the A 
and F chains. These values indicate a low similarity in the first three larger collective modes 
especially for the A chain.    
  Figure 8a, 8b and 8c represent components associated with the first three eigenvectors 
of A and F chains for the isolated domain (in red color) and complex (in black color) 
simulations. Figure 9 shows the RMSF associated with the first three eigenvectors (a, b and c) of 
the A (in sky blue) and F (in tan color) chains in solution (a1, b1 and c1) and complex (a2, b2 
and c2) simulations, respectively. 
In the complex simulation, the first collective motion (Figure 9a1) of the A chain 
involves the turn region between the residues 44 – 48 (the highest eigenvector component is for 
the residue R47 that is involved in the substrate binding), the loop regions D/E (residues 130 – 
138), F/G (residues 190 – 196), K/L loop (residue 385 – 390) and the C-terminus loops (residues 
425 – 432 and 452 – 458). The collective mode involves the turn region 44 – 48  and F/G loop is 
related to the closing and opening of the substrate access channel.44 Different residues (F390, 
K391, P392, F393, A399, and C400) of the latter K/L loop region are present in most of the ET 
pathways found in the complex simulation. The residue F393, a part of the K/L loop later region, 
is involved in the FMN domain binding and found to be involved in the ET tunneling in the first 
cluster of the AF chain (Pathway 1). F393, a conserved HEME-binding residue, is considered a 
key residue in the thermodynamics control of the P450BM-3 catalytic activity.45,46 In the 
complex simulation, the first collective mode of the F chain involves the major contribution of 
the Lα2 loop with slightly higher components of the inner FMN binding loop Lβ2 and Lβ3. The 
collective modes involving Lα2 and Lβ3 might facilitate the ET tunneling from the FMN to 
HEME cofactors. In the FMN/HEME complex, the collective modes of both the domains were 
synchronized to relate the ET tunneling and the change in the substrate binding region. The 
effect was clearly seen when the first eigenvectors of the AF chain was compared with that of the 
isolated A and F chains in the complex simulation (reported in Figure S6a and S7a in SI). In both 
AF and, individual A and F chain, the first eigenvector show fluctuations in the same regions 
with higher values for the AF chain. The second collective mode of the A chain involves mainly 
the motion in D/E and G/H loops, β- sheets in K/L regions and A/B region and the third 
collective motion was restricted to D/E and G/H loops and C-terminus loop (residues 425 – 432). 
The F chain shows the involvement of Lα2 and Lβ2 loops and the C-terminus region in the 
second collective mode, while involvement of Lα2, Lβ3 and Lβ5 loops in the third eigenvector. 
In the AF chain, the collective modes associated with the first two eigenvectors belongs to the 
movement of the F chain towards the A chain to decrease the distance between the FMN and 
HEME cofactors and show slightly higher fluctuation than in the individual chains. In the third 
eigenvector, the major difference was observed mainly in Lβ3 and Lα2 loops of the F chain with 
higher fluctuations. The collective motions associated with the first three eigenvectors of the AF 
chain are reported in Figure S7a, S7b and S7c of SI, respectively. 
 In the isolated A chain, the first collective mode (Figure 9a2) has higher values of 
components at the end of C helix (residue 103 – 107) and C-terminus (residues 452 – 458). Other 
regions involved in the first collective mode were D/E, E/F, F/G and K/L loops (residue 385 – 
390). Altogether, the motion is related to the change in the binding regions for the substrate and 
the FMN domain.   
 The first collective mode of the isolated F chain shows higher components in Lα2 and 
Lβ2 loops, and slightly high values in Lβ3 and Lβ4 loops. In the simulations of individual 
domains, the collective motions is more related to the binding of the FMN cofactor in the F chain 
and is restricted to the substrate binding region in the A chain. The second collective mode of the 
A chain involves mainly the motion in D/E, E/F and F/G loops and it is restricted to the F/G 
region only in the third collective motion. In the F chain, the Lα2 and Lβ2 loops are involved in 
the second collective mode and Lα2 and Lβ3 loops in the third mode. 
 Figure 10 shows the projection of the AF chain trajectory on the first and second 
eigenvectors. The projection is characterized by a V shaped distribution. The left and right 
strokes will be named Region I and II, respectively. The Region I in the interval [-6:0] of the x-
axis correspondes, approximately, to the first 50 ns of the simulation and the other the last 50 ns. 
In Figure 10b, 10c and 10d, the values of KET , calculated along the pathways 1, 2 and 7 for each 
conformation along the trajectories, are averaged on the eigenvector plane using a square grid of 
bin 0.05 nm. For the pathway 1, the highest values of KET are localized in Region I (see Figure 
10b) On the contrary, the pathway 7 (sampled at 100 ns, see Table 2) has the largest value KET in 
the Region II of the projection (see Figure 10d). Finally, Pathway 2 shows a uniform distribution 
of the high value of KET in the Region I and partial distribution in the Region II (see Figure 10c). 
The results indicate that the essential modes do have an effect on the activation of different 
pathways responsible for ET tunneling along the trajectory that is consistent with the previous 
study on the effect of the protein dynamics on the ET process.47-51 
 
 Conclusions 
 We performed the MD simulations of the P450BM-3 HEME and FMN domains as 
isolated domains or in the complex. The secondary structure and tridimensional structure of the 
two domains do not significant change from crystallographic structure during the 100 ns 
simulations. The isolated FMN domain shows major conformational change in Lα2 loop as 
observed in a previous study.21 In the isolated HEME domain, the major conformational changes 
were observed in the FMN binding region especially in C helix and H/I and K/L (residue 385 – 
395) loops. Conversely, the FMN/HEME complex undergoes an inter-domain conformational 
rearrangement in the first 10 ns of the simulation that increased its compactness (with the change 
in the Rg values from 2.42 nm (in the crystal structure) to 2.33 nm) and reduced of 22% in the 
FMN/HEME minimum distance from 1.81 nm (in the crystal structure) to an average 1.41± 0.09 
nm. The change of the average distance between the FMN and HEME domains confirm the 
previous theoretical and experimental observation11,52,53 about the non-competent arrangement for 
an efficient ET of the crystallographic FMN/HEME complex. The conformations obtained from 
our complex simulation have minimum distances between the FMN to HEME cofactors that 
provide ET rate consistent with experimental data.43  
 Both the FMN and HEME domains show difference in the collective modes in solution 
compared to the ones in the FMN/HEME complex. In the latter, the collective motions were 
clearly associated with the change of the ET pathways observed during the simulations. 
In summary, the results of this theoretical study are consistent with the available 
experimental data and provide further insight at the atomistic level to understand the structure 
and dynamics of this complex enzyme. In particular, the structural determinants of the inter-
domain ET mechanism can put forward important information to extend the knowledge of the 
P450BM-3 enzyme for a better exploitation of the enzyme in biotechnological applications. In 
fact, the results of this study have identified the residues, N319, L322, F390, K391, P392, F393, 
A399, C400 and Q403 of HEME domain, and M490 of FMN domain, to be involved in the ET 
tunneling from FMN to HEME cofactor. These amino acids can be the target of the site directed 
evolution experiments to prove their significance in the ET mechanism.   
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the secondary structure elements of the HEME and FMN domains, the distance between water 
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AF, A and F chains in solution and complex simulation and the RMSF of the protein backbone 
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corresponding eigenvector of AF chain in the complex simulation. 
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 Table titles 
  
Table 1: Simulation summary of P450BM-3 domains in solution 
Table 2: ET tunneling pathways in the FMN/HEME complex of P450BM-3 
  
Figure legends 
 
 Figure 1: a) HEME cofactor and b) FMN cofactor are in stick representation, colored by 
elements such as, oxygen in red, nitrogen in blue, hydrogen in green, iron or phosphorus in 
orange and carbon in gray, with the atomic labeling according to their GROMOS9623 topology. 
   
Figure 2: a) Backbone RMSD and b) Rg with respect to the crystal structure as a function of 
time for the AF chain (black), A of AF chain (red), F of AF chain (green), A chain (blue) and F 
chain (orange). 
 
Figure 3: Backbone RMSD (a) and RMSF (b) per residue with respect to the crystal structure for 
the isolated domains (in red) and in the complex (in black) MD simulations. The green vertical 
line separates the HEME and FMN domains. Horizontal bars, in blue and orange color represent 
helices (labeled) and beta sheets, respectively. The regions involved in the cofactor binding are 
represented by horizontal bars in purple color. Vertical bars in grey color show the interaction 
between the HEME and FMN domains. (c) The HEME and FMN domains are in the cartoon 
representation in sky blue and tan color, respectively. The HEME and FMN cofactors are in red 
and green color, respectively. Helices, cofactors, FMN binding regions and, N- and C- termini 
are labeled. 
 
Figure 4:  The median AF chain conformation of the first cluster superimposed with the crystal 
structure. In the crystal structure, the A and F chains are in the cartoon representation in dark and 
light blue color, respectively. For the complex simulation, the A and F chain are in surface (in 
tan color) and cartoon representation (in orange color), respectively. The HEME and FMN 
cofactors and the FMN/HEME distance (by dotted line) are represented in green and red color in 
the crystal structure and in the equilibrated conformation, respectively. The purple colored arrow 
shows the displacement of the FMN domain towards the HEME domain after conformational 
rearrangement. 
 
Figure 5: (a) Minimum distance and (b) the number of contacts (less than 0.6 nm) between the 
backbone atoms of the A and F chains. Horizontal red color line shows the minimum distance 
and the number of contacts in the crystal structure. 
 
Figure 6: Minimum distance between P45Cα and A191Cα as a function of time for the A chain in 
the solution (in red color) and complex (in black color) simulation. 
 
Figure 7: ET tunneling from the FMN isoalloxazine ring (C8 atom) (in gray color) to the HEME 
iron (in black color) is represented by red color tubes in a) the crystal structure, b) the 
conformation of the first cluster (50.6 ns) and c) the conformation at the end of simulation 100 
ns. The amino acids within the distance of 0.50 nm from both the cofactors are shown in licorice 
representation and colored by element type (oxygen in red, carbon in cyan and nitrogen in blue 
color) and their associated secondary structure in the cartoon representation in sky blue color for 
the HEME and FMN domains in orange color. The residues involved in the FMN/HEME ET 
tunneling are represented and labeled in green color. 
 
Figure 8: The components for the (a) first, (b) second and (c) third eigenvectors of the A and F 
chain in the solution (red color) and complex (black color) simulations. The green vertical line 
separates the HEME and FMN domains. Horizontal bars represent helixes (labeled) and beta 
sheets in blue and orange color, respectively. The regions involved in the cofactor binding are 
represented by horizontal bars in purple color. 
 
Figure 9: The RMSF of the protein backbone atoms along the first (a), second (b) and third (c) 
eigenvectors after projection of the trajectory on the corresponding eigenvector of the A and F 
chain in the complex (a1, b1 and c1) and the isolated domain (a2, b2 and c2) simulation. The 10 
sequential frames represent the extension of the fluctuations in the trajectories along the 
eigenvectors. The first extreme conformation is shown in green color and last extreme in violet 
color. Other conformations of the A and F chain are in sky blue and tan color, respectively. 
Helices and loops in the FMN domain are labeled. N and C indicate the N- and C-termini of the 
P450BM-3 domains (labeled in red color). 
 
Figure 10: (a) The 2D projection of AF chain trajectory onto the corresponding first two 
eigenvectors obtained from the backbone atoms covariance matrixes. (b), (c) and (d) show the 
projection of ET pathway 1, 2 and 7 on the first and second eigenvectors of AF chain. 
 
